Send SMS
+918045479081

Ramucirumab Injection

Ramucirumab Injection
Ramucirumab Injection
Send Inquiry
Product Code : at
Price And Quantity
  • Minimum Order Quantity
  • 1 Unit
  • Price Range
  • 2771.00 - 2785.00 USD ($)/Unit
  • Price
  • 2770 USD ($)/Unit
Product Specifications
  • Drug Type
  • Injection
  • Ingredients
  • Ramucirumab
Product Description

CYRAMZA(ramucirumab) as a single agent, or in combination with paclitaxel, is indicated for the treatment of patients with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

CYRAMZA (ramucirumab), in combination with docetaxel, is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with disease progression on or after platinum-based chemotherapy. Patients with epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving CYRAMZA.

Trade Information
  • FOB Port
  • mumbai
  • Payment Terms
  • Paypal, Telegraphic Transfer (T/T), Cheque
  • Delivery Time
  • 1 Week
  • Sample Policy
  • Contact us for information regarding our sample policy
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

KAVYA PHARMA
X


Back to top